Connolly, Dominic and McElrath, Karen (2007) Nalbuphine (Nubain): Non-prescribed use, injecting, and risk behaviors for bloodborne viruses. Contemporary Drug Problems, 33, (2), pp. 321-340. https://doi.org/10.1177%2F009145090603300207.
Preview | Title | Contact |
---|---|---|
|
PDF (Nalbuphine (Nubain): Non-prescribed use, injecting, and risk behaviors for bloodborne viruses)
903kB |
Nalbuphine hydrochloride is a synthetic opiate with agonist-antagonist properties that has been prescribed for pain relief in several countries in North and Central America, Europe, and elsewhere. This drug has been marketed under the tradename NubainReg and was believed to have low potential for dependence. Previous research has noted misuse among bodybuilders, weightlifters, and users of anabolic steroids. This study examines patterns of nalbuphine misuse and injecting behaviours that pose risk for blood-borne viruses among ten respondents residing largely in one community in Ireland. Contrary to other research findings, most individuals had no history of weightlifting and no experience with the use of anabolic steroids. Most of the respondents had injected nalbuphine several times per day, and reported frequent injection of stimulants. Implications of the findings are discussed.
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease
J Health care, prevention, harm reduction and treatment > Risk and protective factors
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > Europe > Northern Ireland
Repository Staff Only: item control page